• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非药物干预对中国宁波新冠肺炎疫情期间及之后儿童感染流行病学特征的影响

Influence of non-pharmaceutical interventions on epidemiological characteristics of infection in children during and after the COVID-19 epidemic in Ningbo, China.

作者信息

Jiang Min, Zhang Hui, Yao Fangfang, Lu Qinhong, Sun Qian, Liu Zhen, Li Qingcao, Wu Guangliang

机构信息

Department of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China.

Department of Clinical Laboratory, Ninghai County Chengguan Hospital, Ningbo, China.

出版信息

Front Microbiol. 2024 Jul 17;15:1405710. doi: 10.3389/fmicb.2024.1405710. eCollection 2024.

DOI:10.3389/fmicb.2024.1405710
PMID:39086655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11288959/
Abstract

BACKGROUND

Since the outbreak of COVID-19, China has implemented a series of non-pharmaceutical interventions (NPIs), effectively containing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as various respiratory pathogens. With the continuous relaxation of restrictions, China has entered a new phase of the post-pandemic era. However, the epidemiological differences of (MP) between the two phases in Ningbo and even in China remain unclear.

METHODS

Data of children aged 0-14 years who visited the Ningbo Medical Center LiHuiLi Hospital due to acute respiratory tract infections from January 2020 to December 2023 were collected. PCR was used to detect 13 respiratory pathogens and the macrolide-resistance of .

RESULTS

Among 10,206 children, 2,360 were infected with MP (23.12%). Among the total, the MP positive rate during the NPI phase (6.35%) was significantly lower than that during the non-NPI phase (34.28%), while the macrolide resistance rate increased from 62.5% (NPI phase) to 81.1% (non-NPI phase). The rate of MP co-infection increased from 11.2% (NPI phase) to 30.3% (non-NPI phase). MP infection exhibited obvious seasonality, with the highest prevalence in autumn (30.0%) followed by summer (23.6%). There were differences in MP positivity rates among different age groups, with the highest among school-age children at 39.5%. During the NPI phase, all age groups were less susceptible to MP, while during the non-NPI phase, the susceptible age for MP was 4-12 years, with 8 years being the most susceptible. The susceptible age for MP co-infection was 0-6 years. MP exhibited antagonistic effects against numerous pathogens. Compared to MP single infection, the proportion of pneumonia was higher in MP co-infection cases.

CONCLUSION

The removal of NPIs significantly impacted the spread of MP, altering population characteristics including age, seasonality, macrolide resistance, and MP co-infection rates.

摘要

背景

自新冠疫情爆发以来,中国实施了一系列非药物干预措施(NPIs),有效遏制了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)以及各种呼吸道病原体的传播。随着限制措施的不断放宽,中国已进入疫情后时代的新阶段。然而,宁波乃至中国两个阶段之间支原体(MP)的流行病学差异仍不清楚。

方法

收集2020年1月至2023年12月因急性呼吸道感染到宁波大学附属李惠利医院就诊的0-14岁儿童的数据。采用聚合酶链反应(PCR)检测13种呼吸道病原体及MP的大环内酯耐药性。

结果

10206名儿童中,2360名感染MP(23.12%)。总体而言,非药物干预阶段MP阳性率(6.35%)显著低于非非药物干预阶段(34.28%),而大环内酯耐药率从非药物干预阶段的62.5%升至非非药物干预阶段的81.1%。MP合并感染率从非药物干预阶段的11.2%升至非非药物干预阶段的30.3%。MP感染呈现明显季节性,秋季患病率最高(30.0%),其次为夏季(23.6%)。不同年龄组MP阳性率存在差异,学龄儿童最高,为39.5%。在非药物干预阶段,各年龄组对MP的易感性均较低,而在非非药物干预阶段,MP的易感年龄为4-12岁,8岁最为易感。MP合并感染的易感年龄为0-6岁。MP对多种病原体表现出拮抗作用。与MP单一感染相比,MP合并感染病例中肺炎的比例更高。

结论

非药物干预措施的解除对MP的传播产生了显著影响,改变了包括年龄、季节性、大环内酯耐药性和MP合并感染率在内的人群特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/e58158e75029/fmicb-15-1405710-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/4c0766d71c95/fmicb-15-1405710-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/79328e942fa3/fmicb-15-1405710-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/b04eadb2ca97/fmicb-15-1405710-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/a12a61ca167e/fmicb-15-1405710-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/0acf0c5dcf39/fmicb-15-1405710-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/e58158e75029/fmicb-15-1405710-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/4c0766d71c95/fmicb-15-1405710-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/79328e942fa3/fmicb-15-1405710-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/b04eadb2ca97/fmicb-15-1405710-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/a12a61ca167e/fmicb-15-1405710-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/0acf0c5dcf39/fmicb-15-1405710-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a30/11288959/e58158e75029/fmicb-15-1405710-g006.jpg

相似文献

1
Influence of non-pharmaceutical interventions on epidemiological characteristics of infection in children during and after the COVID-19 epidemic in Ningbo, China.非药物干预对中国宁波新冠肺炎疫情期间及之后儿童感染流行病学特征的影响
Front Microbiol. 2024 Jul 17;15:1405710. doi: 10.3389/fmicb.2024.1405710. eCollection 2024.
2
Mycoplasma pneumoniae detections in children with lower respiratory infection before and during the COVID-19 pandemic: a large sample study in China from 2019 to 2022.2019 年至 2022 年中国大样本研究:COVID-19 大流行前后下呼吸道感染儿童肺炎支原体检测。
BMC Infect Dis. 2024 Jun 1;24(1):549. doi: 10.1186/s12879-024-09438-2.
3
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to and co-infecting respiratory viruses in Arkansas.由于 SARS-CoV-2 大流行,阿肯色州采取了非药物干预措施,暂时减少了儿童感染 和合并感染呼吸道病毒的病例。
Microbiol Spectr. 2024 Apr 2;12(4):e0290823. doi: 10.1128/spectrum.02908-23. Epub 2024 Mar 15.
4
Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China.中国重庆 COVID-19 大流行限制前后住院儿童肺炎支原体的流行病学特征。
Front Cell Infect Microbiol. 2024 Aug 16;14:1424554. doi: 10.3389/fcimb.2024.1424554. eCollection 2024.
5
[Epidemic characteristics of mycoplasma pneumoniae infection and drug-resistant gene mutations in hospitalized children aged 0-17 in Ningbo City from 2019 to 2023].[2019年至2023年宁波市0-17岁住院儿童肺炎支原体感染流行特征及耐药基因突变情况]
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Jul 6;58(7):1035-1040. doi: 10.3760/cma.j.cn112150-20231123-00368.
6
Epidemiological Study on and Infection of Hospitalized Children in a Single Center During the COVID-19 Pandemic.新冠疫情期间某单中心住院患儿 与 感染的流行病学研究。
Front Cell Infect Microbiol. 2022 Mar 21;12:843463. doi: 10.3389/fcimb.2022.843463. eCollection 2022.
7
Childhood : epidemiology and manifestation in Northeast and Inner Mongolia, China.中国东北和内蒙古的儿童期流行病学和表现。
Microbiol Spectr. 2024 May 2;12(5):e0009724. doi: 10.1128/spectrum.00097-24. Epub 2024 Apr 12.
8
An outbreak of in children after the COVID-19 pandemic, Shanghai, China, 2023.2023年,中国上海,新冠疫情后儿童中的一次[疾病名称缺失]暴发。
Front Microbiol. 2024 Aug 14;15:1427702. doi: 10.3389/fmicb.2024.1427702. eCollection 2024.
9
SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to and Co-Infecting Respiratory Viruses in Arkansas.与阿肯色州因SARS-CoV-2大流行期间非药物干预措施导致的儿科感染及呼吸道病毒合并感染减少存在时间关联。
medRxiv. 2023 Aug 9:2023.08.05.23293566. doi: 10.1101/2023.08.05.23293566.
10
The Epidemiology of Pathogens in Community-Acquired Pneumonia Among Children in Southwest China Before, During and After COVID-19 Non-pharmaceutical Interventions: A Cross-Sectional Study.《新冠疫情非药物干预前后中国西南地区儿童社区获得性肺炎病原体流行病学:一项横断面研究》
Influenza Other Respir Viruses. 2024 Aug;18(8):e13361. doi: 10.1111/irv.13361.

引用本文的文献

1
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities.儿童肺炎支原体感染的再度流行:新出现的挑战与机遇
Curr Opin Infect Dis. 2025 Oct 1;38(5):468-476. doi: 10.1097/QCO.0000000000001126. Epub 2025 Aug 6.
2
Shifting epidemic trends and severity in pediatric Mycoplasma pneumoniae infections in the post-COVID-19 era.新冠疫情后时代小儿支原体肺炎感染的流行趋势与严重程度变化
Ital J Pediatr. 2025 Jul 10;51(1):219. doi: 10.1186/s13052-025-02064-x.
3
Epidemiological association of the COVID-19 pandemic on infections in children in Tianjin, China: a single-centre retrospective study (2017-2024).

本文引用的文献

1
Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.免疫差距的证据:新冠疫情期间抗肺炎支原体抗体下降。
J Infect. 2024 Aug;89(2):106209. doi: 10.1016/j.jinf.2024.106209. Epub 2024 Jun 18.
2
Adenovirus and co-infection as a risk factor for severe community-acquired pneumonia in children.腺病毒及合并感染作为儿童重症社区获得性肺炎的一个危险因素。
Front Pediatr. 2024 Jan 31;12:1337786. doi: 10.3389/fped.2024.1337786. eCollection 2024.
3
Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022.
中国天津新冠疫情大流行与儿童感染的流行病学关联:一项单中心回顾性研究(2017 - 2024年)
BMJ Open. 2025 Jun 17;15(6):e101045. doi: 10.1136/bmjopen-2025-101045.
4
Epidemiological changes of among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024.2017年至2024年中国河南省儿童在新冠疫情之前、期间及之后的流行病学变化。
Microbiol Spectr. 2025 Jul;13(7):e0312124. doi: 10.1128/spectrum.03121-24. Epub 2025 Jun 9.
5
The circulating characteristics of common respiratory pathogens in Ningbo, China, both before and following the cessation of COVID-19 containment measures.中国宁波在停止 COVID-19 防控措施前后常见呼吸道病原体的循环特征。
Sci Rep. 2024 Oct 28;14(1):25876. doi: 10.1038/s41598-024-77456-w.
6
Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of Pneumonia in Children and Adolescents in South Korea.韩国儿童和青少年肺炎的临床表现、大环内酯类耐药性及治疗利用趋势
Microorganisms. 2024 Aug 31;12(9):1806. doi: 10.3390/microorganisms12091806.
2020-2022 年武汉儿童肺炎支原体肺炎的分子流行病学研究。
BMC Microbiol. 2024 Jan 17;24(1):23. doi: 10.1186/s12866-024-03180-0.
4
Characteristics of the Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends.2019年至2020年韩国疫情特征:大环内酯类耐药性及合并感染趋势
Antibiotics (Basel). 2023 Nov 13;12(11):1623. doi: 10.3390/antibiotics12111623.
5
Mycoplasma pneumoniae: gone forever?肺炎支原体:一去不复返了?
Lancet Microbe. 2023 Oct;4(10):e763. doi: 10.1016/S2666-5247(23)00182-9. Epub 2023 Jun 29.
6
The clinical significance of macrolide resistance in pediatric infection during COVID-19 pandemic.儿童感染大环内酯类耐药在 COVID-19 大流行期间的临床意义。
Front Cell Infect Microbiol. 2023 May 12;13:1181402. doi: 10.3389/fcimb.2023.1181402. eCollection 2023.
7
The molecular characteristics, diagnosis, and treatment of macrolide-resistant in children.儿童大环内酯类耐药的分子特征、诊断与治疗
Front Pediatr. 2023 Mar 2;11:1115009. doi: 10.3389/fped.2023.1115009. eCollection 2023.
8
The effects of the COVID-19 pandemic on community respiratory virus activity.新冠疫情对社区呼吸道病毒活动的影响。
Nat Rev Microbiol. 2023 Mar;21(3):195-210. doi: 10.1038/s41579-022-00807-9. Epub 2022 Oct 17.
9
[Clinical characteristics of infection and factors associated with co-infections in children].[儿童感染的临床特征及合并感染相关因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Sep 10;43(9):1448-1454. doi: 10.3760/cma.j.cn112338-20220321-00210.
10
triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020.触发北京秋冬肺炎疫情:2015 年至 2020 年间的一项多中心、基于人群的流行病学研究。
Emerg Microbes Infect. 2022 Dec;11(1):1508-1517. doi: 10.1080/22221751.2022.2078228.